Your browser doesn't support javascript.
loading
Mean platelet diameter measurements to classify inherited thrombocytopenias.
Fixter, K; Rabbolini, D J; Valecha, B; Morel-Kopp, M-C; Gabrielli, S; Chen, Q; Stevenson, W S; Ward, C M.
Afiliação
  • Fixter K; Department of Haematology and Transfusion Medicine, Royal North Shore Hospital, Sydney, NSW, Australia.
  • Rabbolini DJ; Department of Haematology and Transfusion Medicine, Royal North Shore Hospital, Sydney, NSW, Australia.
  • Valecha B; Northern Blood Research Centre, Kolling institute of Medical Research, University of Sydney, Sydney, NSW, Australia.
  • Morel-Kopp MC; Department of Haematology and Transfusion Medicine, Royal North Shore Hospital, Sydney, NSW, Australia.
  • Gabrielli S; Department of Haematology and Transfusion Medicine, Royal North Shore Hospital, Sydney, NSW, Australia.
  • Chen Q; Northern Blood Research Centre, Kolling institute of Medical Research, University of Sydney, Sydney, NSW, Australia.
  • Stevenson WS; Department of Haematology and Transfusion Medicine, Royal North Shore Hospital, Sydney, NSW, Australia.
  • Ward CM; Northern Blood Research Centre, Kolling institute of Medical Research, University of Sydney, Sydney, NSW, Australia.
Int J Lab Hematol ; 40(2): 187-195, 2018 Apr.
Article em En | MEDLINE | ID: mdl-29143464
ABSTRACT

INTRODUCTION:

Mean platelet volume (MPV) assists the differential diagnosis of inherited thrombocytopenia (IT) but lacks standardisation and varies between automated analysers. Classification of IT based on mean platelet diameter (MPD) has been proposed by an international collaborative study but has not been validated.

METHODS:

To assess the applicability of MPD to classify forms of IT, digital images of blood films from patients with established genetic causes for IT were generated, and the MPD measured (ZEISS Axio-scanner and Image J software) by a blinded reviewer. Comparison was made to the proposed classification system.

RESULTS:

Mean platelet volume was measured in thrombocytopenia with different genetic aetiologies, bilallelic BSS (bBSS) (n = 1), monoallelic BSS (mBSS) (n = 2), MYH9-related disorders (MYH9-RD) (n = 11), GFI1B-related thrombocytopenia (RT) (n = 15), FLI1-RT (n = 2), TUBB1-RT (n = 3), ITGA2B/ITGB3-RT (n = 1), RUNX1-RT (n = 2) and controls (n = 54). bBSS and 82% of MYH9-RD samples had MPD >4 µm which correlated with "IT with giant platelets." Only 55% of samples expected in the "large platelet group" had MPD meeting the classification cut-off (MPD >3.2 µm). FLI1-RT MPD were significantly larger than expected whilst ITGA2B/ITGB3-RT MPD were smaller than proposed. MPD in FPD/AML were "normal."

CONCLUSION:

Platelet MPD measurements are a useful guide to classify IT, but the time taken to record measurements may limit clinical applicability.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Trombocitopenia / Plaquetas Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Int J Lab Hematol Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Trombocitopenia / Plaquetas Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Int J Lab Hematol Ano de publicação: 2018 Tipo de documento: Article